Fmoc-N-α-Methyl-L-valine

Fmoc-N-α-Methyl-L-valine is an Fmoc-protected, N-α-methylated L-valine derivative in which the valine side chain retains the isopropyl functionality while the backbone nitrogen is carbamate-protected by the 9H-fluoren-9-ylmethoxycarbonyl (Fmoc) group. The α-methyl substitution creates a stereodefined, sterically constrained amino acid building block that can influence backbone conformations and protease recognition in peptide contexts. The molecule presents the Fmoc carbamate as a removable protecting group for standard solid-phase peptide synthesis, while the N-α-methylation reduces the availability of the backbone amide for hydrogen-bonding patterns typical of unmethylated residues. The combined presence of the chiral center at the α-carbon and the protected amine functionality makes it a controlled intermediate for peptide coupling chemistry, peptidomimetic construction, and downstream derivatization strategies.

1. Peptide Synthesis

Fmoc-N-α-Methyl-L-valine is used in peptide synthesis workflows to introduce an N-α-methylated valine residue that modulates backbone sterics and can alter secondary-structure propensity in assembled sequences. The Fmoc carbamate enables standard N-protection handling, supporting iterative deprotection/coupling cycles where the amine is generated under controlled conditions for peptide bond formation. The α-methyl stereocenter and the valine isopropyl side chain contribute defined three-dimensional geometry for coupling to adjacent residues and for building conformationally biased peptide analogs. Downstream peptide products can be used as research-grade scaffolds for studying how N-methylation affects stability and molecular recognition in peptide science and medicinal chemistry.

2. Peptidomimetics And SAR

Fmoc-N-α-Methyl-L-valine is applied in peptidomimetic and structure-activity relationship studies where N-α-methylation serves as a targeted modification of amide hydrogen-bonding and conformational flexibility. The protected amino acid derivative format supports incorporation into sequences via peptide coupling-compatible chemistry, enabling systematic variation of N-methylated residues while maintaining a consistent valine side chain identity. The stereochemistry at the α-carbon helps preserve defined chiral presentation, which can be critical when mapping SAR trends across analog series. As a result, the compound can function as a controlled building block for generating analog libraries and for preparing sequence-defined peptide mimics used in SAR workflows.

3. Chiral Building Block Development

Fmoc-N-α-Methyl-L-valine is suitable as a chiral amino acid intermediate for stereoselective synthesis planning in fine chemical and synthetic organic chemistry programs. The L-configuration at the α-carbon and the rigidifying effect of the α-methyl substituent provide a defined stereochemical handle for constructing chiral peptide fragments and for preparing N-methylated backbone motifs. The Fmoc-protected amine supports orthogonal protection strategies, allowing the compound to be integrated into multi-step syntheses where selective deprotection and coupling are required. Downstream derivatives can include N-methylated peptide fragments, protected amino acid intermediates for fragment assembly, and stereochemically defined building blocks for chiral molecular construction.

4. Protein Engineering

Fmoc-N-α-Methyl-L-valine is used in protein engineering and chemical biology contexts to design peptide segments that mimic modified backbone features found in engineered or naturally constrained systems. The N-α-methylated valine residue can be incorporated into peptide constructs to tune local conformational preferences and to probe how backbone modifications affect molecular recognition interfaces. The Fmoc protection strategy supports reliable incorporation into sequence-defined peptides that can serve as inputs for protein-binding studies, domain-mapping assays, or engineered binding scaffolds. The resulting N-methylated peptide analogs can then be used to evaluate structure-function relationships at the interface level using amino acid chemistry-compatible workflows.

5. Pharmaceutical Manufacturing

Fmoc-N-α-Methyl-L-valine is relevant to pharmaceutical manufacturing and process chemistry for producing sequence-defined peptide intermediates that contain N-methylated residues. The Fmoc group provides a robust, industry-compatible protecting group format for solid-phase or automated peptide assembly routes, where controlled deprotection and coupling steps are central to reproducible manufacturing. The N-α-methylated backbone motif can be used to prepare peptide intermediates designed for improved chemical stability profiles during downstream processing and formulation development. The compound therefore serves as a practical amino acid building block for industrial peptide synthesis, enabling consistent preparation of protected peptide fragments used in larger scale manufacturing campaigns.

6. Analytical Research Standards

Fmoc-N-α-Methyl-L-valine is utilized in analytical research to generate reference materials and calibration components for monitoring N-methylated peptide fragments in method development and characterization. The defined stereochemistry and the presence of the Fmoc-protected amine allow the compound to serve as a structural marker when developing LC-MS, HPLC, or peptide mapping workflows that distinguish backbone-modified residues. The valine side chain identity and N-α-methyl signature support unambiguous interpretation of fragmentation patterns and retention behavior for peptide analytics. The resulting analytical standards can be applied to quality control of peptide synthesis intermediates and to verification of sequence-defined incorporation in amino acid derivative production.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides